Agarwal Shefali
- SEC CIK
- 0001746830
No open-market purchases or sales filed in the past year.
Current role at each company
- FATE Fate Therapeutics IncDirectoras of Jun 15, 2026
- GRTS Gritstone bio, Inc.Directoras of Apr 8, 2025
- EPZM Epizyme, Inc.Other: See Remarksas of Aug 16, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Agarwal Shefali as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FATE Fate Therapeutics Inc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2022 (view filing) | Jun 7 | 1 day | Agarwal ShefaliDirector | SSale | −841 | $21.89 | −$18.4K | −31.4%1.84K after | |
| Jun 8, 2022 (view filing) | Jun 3 | 5 days | Agarwal ShefaliDirector | SSale | 0 | – | $0 | 0.0%2.68K after | Amended |
EPZM Epizyme, Inc.
Other: See Remarks4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2022 (view filing) | Feb 7 | 2 days | Agarwal ShefaliSee Remarks | SSaleCommon Stock, par value $0.0001 | −1.06K | $1.50 | −$1.59K | −0.7%156.4K after | |
| Feb 4, 2022 (view filing) | Feb 2 | 2 days | Agarwal ShefaliSee Remarks | SSaleCommon Stock, par value $0.0001 | −2.64K | $1.37 | −$3.62K | −1.6%157.4K after | |
| Jan 28, 2022 (view filing) | Jan 26 | 2 days | Agarwal ShefaliSee Remarks | SSaleCommon Stock, par value $0.0001 | −2.92K | $2.02 | −$5.90K | −1.8%160.1K after | |
| Dec 7, 2021 (view filing) | Dec 6 | 1 day | Agarwal ShefaliSee Remarks | SSaleCommon Stock, par value $0.0001 | −1.78K | $2.93 | −$5.22K | −1.1%163.0K after |